Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Excess mortality in solid organ transplant recipients hospitalized with COVID‐19: A large‐scale comparison of SOT recipients hospitalized with or without COVID‐19
Karola Jering, Martina M. McGrath, Finnian R. Mc Causland, et al.
Clinical Transplantation (2021) Vol. 36, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic
Ailish Nimmo, Dale Gardiner, Ines Ushiro‐Lumb, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1312-1329
Open Access | Times Cited: 76
Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic
Shigeyoshi Yamanaga, Keita Shimata, Satoko Ohfuji, et al.
American Journal of Transplantation (2024) Vol. 24, Iss. 8, pp. 1495-1508
Open Access | Times Cited: 7
Incidence, Risk Factors, and Outcomes of COVID-19 Infection in a Large Cohort of Solid Organ Transplant Recipients
Amandeep Sahota, Andy Tien, Janis F. Yao, et al.
Transplantation (2022) Vol. 106, Iss. 12, pp. 2426-2434
Open Access | Times Cited: 29
Solid organ transplantation from COVID positive donors in the United States: Analysis of United Network for Organ Sharing database
Abhay Dhand, Kenji Okumura, Christopher Nabors, et al.
Transplant Infectious Disease (2022) Vol. 25, Iss. 1
Open Access | Times Cited: 27
Emerging anti-spike monoclonal antibodies against SARS-CoV-2
Eloy E. Ordaya, Raymund R. Razonable
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 191-201
Closed Access | Times Cited: 4
COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
Abhay Dhand, Raymund R. Razonable
Current Transplantation Reports (2022) Vol. 9, Iss. 1, pp. 26-34
Open Access | Times Cited: 21
Excess Mortality Among Solid Organ Transplant Recipients in the United States During the COVID-19 Pandemic
Jacob A. Clarke, Timothy L. Wiemken, Kevin Korenblat
Transplantation (2022) Vol. 106, Iss. 12, pp. 2399-2407
Open Access | Times Cited: 20
Sotrovimab for Treatment of COVID-19 in Solid Organ Transplant Recipients
Abhay Dhand, Kenji Okumura, Kevin Wolfe, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. e336-e337
Open Access | Times Cited: 19
Viral cultures, cycle threshold values and viral load estimation for assessing SARS-CoV-2 infectiousness in haematopoietic stem cell and solid organ transplant patients: a systematic review
Tom Jefferson, Elizabeth Spencer, John Conly, et al.
Journal of Hospital Infection (2022) Vol. 132, pp. 62-72
Open Access | Times Cited: 19
Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States
Aditya Sharma, Aditi Sharma, Ayman O. Soubani
Annals of Thoracic Medicine (2024) Vol. 19, Iss. 1, pp. 87-95
Open Access | Times Cited: 3
COVID-19 Outcomes and Vaccinations in Swedish Solid Organ Transplant Recipients 2020–2021: A Nationwide Multi-Register Comparative Cohort Study
John Mackay Søfteland, Huiqi Li, Jesper Magnusson, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 271-271
Open Access | Times Cited: 3
Data mining and safety analysis of traditional immunosuppressive drugs: a pharmacovigilance investigation based on the FAERS database
Juanjuan Li, Li Chen, Yang Zhao, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 4, pp. 513-525
Closed Access | Times Cited: 3
Coronavirus Disease-2019 in the Immunocompromised Host
Christopher D. Bertini, Fareed Khawaja, Ajay Sheshadri
Clinics in Chest Medicine (2022) Vol. 44, Iss. 2, pp. 395-406
Open Access | Times Cited: 18
Characterization of Early-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients Who Received Tixagevimab-Cilgavimab Prophylaxis
Eloy E. Ordaya, Elena Beam, Joseph D. Yao, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 7
Open Access | Times Cited: 17
COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study
Víctor Moreno‐Torres, María Martínez‐Urbistondo, Jorge Calderón‐Parra, et al.
International Journal of Infectious Diseases (2023) Vol. 134, pp. 154-159
Open Access | Times Cited: 9
COVID-19 Vaccine Efficacy and Immunogenicity in End-Stage Renal Disease Patients and Kidney Transplant Recipients
Nicolas F. Moreno, Robert McAdams, John A. Goss, et al.
Current Transplantation Reports (2022) Vol. 9, Iss. 3, pp. 174-184
Open Access | Times Cited: 14
The Association of Physical Distancing Behaviors to Avoid COVID-19 with Health-Related Quality of Life in Immunocompromised and Non-Immunocompromised Individuals: The Patient-Informed Protocol for the Observational, Cross-Sectional EAGLE Study (Preprint)
Paul Williams, Timothy A. Herring, Renata Yokota, et al.
JMIR Research Protocols (2024) Vol. 13, pp. e52643-e52643
Open Access | Times Cited: 2
Molnupiravir for Treatment of COVID-19 in Solid Organ Transplant Recipients
Abhay Dhand, Kenji Okumura, Suguru Ohira, et al.
Transplantation (2023) Vol. 107, Iss. 6, pp. e182-e183
Open Access | Times Cited: 7
Technologies During the COVID-19 Pandemic: Teleconsultation in Care Management for Patients Undergoing Liver Transplant
Neide da Silva Knihs, Ariadne Matzembacher da Silva, Maria Augusta Dietrich, et al.
Transplantation Proceedings (2022) Vol. 54, Iss. 5, pp. 1324-1328
Open Access | Times Cited: 11
Real‐world experience of tixagevimab‐cilgavimab pre‐exposure prophylaxis in orthotopic heart transplant recipients
Eloy E. Ordaya, Eibhlin Higgins, Paschalis Vergidis, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 3
Closed Access | Times Cited: 6
Coronavirus Disease-2019 in the Immunocompromised Host
Christopher D. Bertini, Fareed Khawaja, Ajay Sheshadri
Infectious Disease Clinics of North America (2024) Vol. 38, Iss. 1, pp. 213-228
Closed Access | Times Cited: 1
Evolution of the impact of the COVID‐19 pandemic on heart transplant recipients: Decreasing risk, improving perspective
Juan Carlos López‐Azor, Irene Marco Clement, Javier González Martín, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 2
Open Access | Times Cited: 1
Clinical characteristics of liver transplant recipients with COVID-19 and analysis of risk factors for the severe disease
Sunya Fu, Dawei Chen, Yuqin Zhang, et al.
The Journal of Infection in Developing Countries (2024) Vol. 18, Iss. 04, pp. 542-549
Open Access | Times Cited: 1
Impact of COVID-19 on liver transplant recipients: A nationwide cohort study evaluating hospitalization, transplant rejection, and inpatient mortality
Faisal Inayat, Pratik Patel, Hassam Ali, et al.
World Journal of Transplantation (2024) Vol. 14, Iss. 2
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top